INHIBITEURS DE PLA2 ET HMG-COA POUR LE TRAITEMENT DES AFFECTIONS PATHOLOGIQUES PROVOQUANT UNE HEMOLYSE, UN ;DEME CEREBRAL, ET UNE INSUFFISANCE RENALE AIGUE
Provided are methods for treatment of pathological conditions causing hemolysis, cerebral edema, acute kidney injury and non-anaphylactic shock, including envenomation, trauma, cerebral malaria and mast-cell diseases using at least one PLA2 inhibitor, alone or in combination with other agents. The unexpected versatility of PLA2 inhibitors, their dosage forms and combinations make them candidates as essential medicines for the developing world.